No association between BMD and prevalent vertebral fractures in liver transplant recipients at time of screening before transplantation

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 10, 2014, Pages 3677-3685

  Krol, Charlotte G ^a   Dekkers, Olaf M ^a   Kroon, Herman M ^a   Rabelink, Ton J ^a   Van Hoek, Bart ^a   Hamdy, Neveen A T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL EVALUATION; COMPRESSION FRACTURE; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; END STAGE LIVER DISEASE; FEMALE; FEMUR NECK; GRAFT RECIPIENT; HUMAN; INFANT; INTRAHEPATIC CHOLESTASIS; LIVER TRANSPLANTATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PREOPERATIVE EVALUATION; RISK FACTOR; SEX DIFFERENCE; SPINE FRACTURE; SPINE RADIOGRAPHY; BIOLOGICAL MODEL; BONE DISEASES, METABOLIC; MASS SCREENING; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREOPERATIVE CARE; PREVALENCE; RETROSPECTIVE STUDY; SPINAL FRACTURES;

ADULT; AGED; BONE DENSITY; BONE DISEASES, METABOLIC; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MASS SCREENING; MIDDLE AGED; MODELS, BIOLOGICAL; OSTEOPOROSIS; PREOPERATIVE CARE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL FRACTURES;

EID: 84907612410     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1469     Document Type: Article

References (35)

1. Guichelaar MM, Schmoll J, Malinchoc M, Hay JE. Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors. Hepatology. 2007;46(4):1198-1207.
2. Leidig-Bruckner G, Hosch S, Dodidou P, et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet. 2001;357(9253):342-347.
3. Monegal A, Navasa M, Guañabens N, et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int. 2001;12(6):484-492.
4. Alcalde Vargas A, Pascasio Acevedo JM, Gutiérrez D, et al. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation. Transplant Proc. 2012;44(6):1496-1498.
5. Carey EJ, Balan V, Kremers WK, Hay JE. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl. 2003;9(11):1166-1173.
6. Guichelaar MM, Malinchoc M, Sibonga JD, Clarke BL, Hay JE. Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease. J Bone Miner Res. 2003;18(12):2190-2199.
7. Monegal A, Guañabens N, Suárez MJ, et al. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial. Transpl Int. 2009;22(2):198-206.
8. Premaor MO, Das TK, Debiram I, et al. Fracture incidence after liver transplantation: results of a 10-year audit. QJM. 2011;104(7):599-606.
9. Hardinger KL, Ho B, Schnitzler MA, et al. Serial measurements of bone density at the lumbar spine do not predict fracture risk after liver transplantation. Liver Transpl. 2003;9(8):857-862.
10. Bai XL, Liang TB, Wu LH, et al. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases. Transplant Proc. 2007;39(10):3182-3185.
11. Guichelaar MM, Kendall R, Malinchoc M, Hay JE. Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl. 2006;12(9):1390-1402.
12. Trautwein C, Possienke M, Schlitt HJ, et al. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol. 2000;95(9):2343-2351.
13. González-Reimers E, Alvisa-Negrín J, Santolaria-Fernández F, et al. Prognosis of osteopenia in chronic alcoholics. Alcohol. 2011;45(3):227-238.
14. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15(4):721-739.
15. Siris ES, Genant HK, Laster AJ, Chen P, Misurski DA, Krege JH. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int. 2007;18(6):761-770.
16. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-470.
17. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137-1148.
18. Dolgos S, Hartmann A, Isaksen GA, et al. Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based study. Clin Transplant. 2010;24(5):E145-E152.
19. Millonig G, Graziadei IW, Eichler D, et al. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study. Liver Transpl. 2005;11(8):960-966.
20. Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int. 2001;69(6):321-326.
21. Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH. Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl. 2004;10(5):648-653.
22. Peris P, Parés A, Guañabens N, et al. Bone mass improves in alcoholics after 2 years of abstinence. J Bone Miner Res. 1994;9(10):1607-1612.
23. Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res. 2002;17(6):1051-1056.
24. Ninkovic M, Love S, Tom BD, Bearcroft PW, Alexander GJ, Compston JE. Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J Hepatol. 2002;37(1):93-100.
25. Floreani A, Fries W, Luisetto G, et al. Bone metabolisminorthotopic liver transplantation: aprospective study. Liver Transpl Surg. 1998;4(4):311-319.
26. Pennisi P, Trombetti A, Giostra E, Mentha G, Rizzoli R, Fiore CE. Pamidronate and osteoporosis prevention in liver transplant recipients. Rheumatol Int. 2007;27(3):251-256.
27. Delmas PD, van de Langerijt L, Watts NB, et al. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res. 2005;20(4):557-563.
28. Kim N, Rowe BH, Raymond G, et al. Underreporting of vertebral fractures on routine chest radiography. AJR Am J Roentgenol. 2004;182(2):297-300.
29. Giannini S, Nobile M, Dalle Carbonare L, et al. Vertebral morphometry by x-ray absorptiometry before and after liver transplant: a cross-sectional study. Eur J Gastroenterol Hepatol. 2001;13(10):1201-1207.
30. Ninkovic M, Skingle SJ, Bearcroft PW, Bishop N, Alexander GJ, Compston JE. Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol. 2000;12(8):931-935.
31. Black DM, Arden NK, Palermo L, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14(5):821-828.
32. Melton LJ 3rd, Atkinson EJ, Cooper C, O'Fallon WM, Riggs BL. Vertebral fractures predict subsequent fractures. Osteoporos Int. 1999;10(3):214-221.
33. Meys E, Fontanges E, Fourcade N, Thomasson A, Pouyet M, Delmas PD. Bone loss after orthotopic liver transplantation. Am J Med. 1994;97(5):445-450.
34. Melton LJ3rd, Lane AW, Cooper C, Eastell R, O'Fallon WM, Riggs BL. Prevalence and incidence of vertebral deformities. Osteoporos Int. 1993;3(3):113-119.
35. Hernlund E, Svedbom A, Ivergård M, et al Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136.